Clinical and Epidemiologic Characteristics of Bronchial Asthma and Chobla Morbidity during the Covid-19 Pandemic Period

Chronic obstructive pulmonary disease (COPD) and bronchial asthma remain among the most common respiratory diseases in the world, having a significant impact on the quality of life of patients and creating a significant burden on health care systems. According to current data, asthma affects about 8% of the population in the United States, and COPD is diagnosed in 6% of residents. The emergence of the COVID-19 pandemic has created unprecedented challenges for health care systems and significantly impacted the course of chronic respiratory diseases.